Josh Gottheimer (D-NJ)
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
A Democratic resolution with 1 Republican cosponsor · See the cosponsor
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
This resolution recognizes the significance of Charcot-Marie-Tooth disease (CMT) and its impact on people. It notes that CMT causes damage to peripheral nerves and can affect muscle control. The text states that an estimated 126,000 individuals in the United States have this disease. It also mentions that the specific gene causing CMT has not been identified and that federal funding for research actually decreased in 2022 compared to 2021. Finally, the resolution expresses a need for robust research funding through the National Institute of Neurological Disorders and Stroke.
Yes· 3 of 4
- Scored +5
Would people with disabilities be better off under this?
The resolution advocates for increased research funding that directly benefits those living with Charcot-Marie-Tooth disease.
- Scored +5
Does this put more money into scientific research?
The resolution advocates for increased federal investment into neurological research to combat CMT.
- Scored +5
Does this put more money into medical research?
The resolution calls for robust funding for research into Charcot-Marie-Tooth disease and other rare diseases.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Research Funding: The resolution expresses that CMT should receive robust funding for research to ensure all is being done to study the disease at the National Institute of Neurological Disorders and Stroke (Resolution, Section 2). This could lead to better understanding of the disease.
-
Continued Investment in Rare Diseases: The resolution expresses a need to continue investing in research efforts to tackle CMT and other rare diseases that currently have no cure (Resolution, Section 3). This could benefit those suffering from various incurable rare diseases.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would people with disabilities be better off under this? — The resolution advocates for increased research funding that directly benefits those living with Charcot-Marie-Tooth disease.
- Education And Technology
- Does this put more money into scientific research? — The resolution advocates for increased federal investment into neurological research to combat CMT.
- Healthcare
- Does this put more money into medical research? — The resolution calls for robust funding for research into Charcot-Marie-Tooth disease and other rare diseases.
- Social Issues And Justice
- Does this expand the rights of people with disabilities? — By advocating for research into a disease that affects muscle control and nerve function, it supports the needs of the disabled community.
- 2/25/2026
- Submitted in House
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
Don BaconRepublican · Nebraska